Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.
Chigg Away Benzocaine 50 mg/mL Lotion, 118 mL — NDC 82645-918-94 (Billing 82645-0918-94)
by Pharma Nobis, LLC · 118 mL in 1 BOTTLE, PLASTIC
This is a package of 118 mL of Chigg Away Benzocaine 50 mg/mL Lotion from Pharma Nobis, LLC, marketed since Jan 2008 and currently FDA-listed, this package's marketing is listed to end Dec 2026. It is this product's only package size.
NDC 82645-0918-94
🏷️ FDA NDC (as labeled)
82645-918-94
billing pads the product segment with a zero
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
NDC database record
One package, one record: these facts belong to NDC 82645-918-94 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 82645 labeler · 918 product · 94 package
- Package marketed since
- Jan 1, 2008
- Package marketing ended
- Dec 31, 2026
- Sample package
- No — commercial package
- Barcode (UPC)
- 0701277018988, 0050428312872
- FDA record last changed
- Jul 24, 2026
⚠️
Other active recalls for Benzocaine (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0602-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0605-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0601-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0603-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0604-2026
Class II · May 21, 2026 — Defective container:may contain bottles with incomplete seals (Keystone Industries) · FDA recall D-0606-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA NDC (as labeled)
82645-918-94
Product NDC
82645-918
11-digit billing NDC
82645091894
RxCUI
1373322
UNII
U3RSY48JW5
UPC
0701277018988, 0050428312872
Application #
M017
SPL Set ID
e42fa1c6-d804-630f-e053-2995a90add6b
Established class (EPC)
Standardized Chemical Allergen
Physiologic effect
Increased Histamine Release; Cell-mediated Immunity
Chemical class
Allergens
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2008-01-01
Marketing end
2026-12-31
Route
TOPICAL
Dosage form
LOTION
Substance
BENZOCAINE
Quick answers
- RxCUI (RxNorm): 1373322
Why two NDCs?
The FDA registers this code as 82645-918-94 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 82645-0918-94. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- FDA label on DailyMed · label index refreshed Oct 8, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 8, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 8, 2026
RxNorm drug class
This medicine belongs to the Standardized Chemical Allergen class.
Pharmacologic class
Standardized Chemical Allergen
Drug family (ATC)
Local anesthetics, Anesthetics for topical use, Esters of aminobenzoic acid
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
- RxClass (NLM) · catalog refreshed Oct 8, 2026
Clinical
🧪 What is this product?
Chigg Away Benzocaine 50 mg/mL Lotion is a topical lotion containing benzocaine, a local anesthetic. This product is marketed as an over-the-counter monograph drug, meaning it follows FDA's established rule-book for topical anesthetics rather than undergoing individual product review. Benzocaine is typically used to numb skin and provide temporary relief from minor itching and irritation on the surface of the skin.
Patient education
Supplement & herbal interactions
Some supplements/herbs that may interact with Benzocaine — tap one for details:
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
- MedlinePlus (NLM) · refreshed Oct 8, 2026
- FDA label on DailyMed · label index refreshed Oct 8, 2026
💬 Questions about Benzocaine?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 9, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 82645-0918-94 You're viewing this Main listing | 118 mL in 1 BOTTLE, PLASTIC | 2008-01-01 | Dec 31, 2026 | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Chigg Away 50 mg/mLthis 82645-0918-94 | Pharma | 118 ml | — | — | FDA listed | — |
| Chigg Away 50 mg/mL 82895-0857-05 | Westlake | 118 ml | — | — | Discontinued | — |
| HIGHER CONTROL Male Climax Control Lubricating 50 mg/mL 70742-0180-02 | Product | 60 ml | — | — | FDA listed | — |
| BODY ACTION PRODUCTS Climax Control Gel 50 mg/mL 70742-0282-00 | PRODUCT | 60 ml | — | — | FDA listed | — |
| BODY ACTION PRODUCTS Endless Love for Men 50 mg/mL 70742-0284-00 | PRODUCT | 50 ml | — | — | FDA listed | — |
| BODY ACTION PRODUCTS Butt Eze Benzocaine 50 mg/mL 70742-0286-00 | PRODUCT | 60 ml | — | — | FDA listed | — |
| BODY ACTION PRODUCTS Prolong Lubricating 50 mg/mL 70742-0288-00 | PRODUCT | 60 ml | — | — | FDA listed | — |
| BODY ACTION PRODUCTS Higher Control Male Climax 50 mg/mL 70742-0292-00 | PRODUCT | 60 ml | — | — | FDA listed | — |
| Endless Love For Men 50 mg/mL 70742-0360-50 | Body | 50 ml | — | — | FDA listed | — |
| INTIMALE Benzocaine Delay Gel 50 mg/mL 81923-0369-00 | SKINS | 15 ml | — | — | FDA listed | — |
| SKINS DELAY Climax Control Benzocaine Gel 50 mg/mL 81923-0365-00 | SKINS | 3 ml | — | — | FDA listed | — |
| Chigg Away 50 mg/mL 45591-0002-04 | Pierson | 118 ml | — | — | FDA listed | — |
| BODY ACTION PRODUCTS Anal Glide Extra 50 mg/mL 70742-0287-00 | PRODUCT | 60 ml | — | — | FDA listed | — |
| POWERECT Benzocaine Male Delay Gel 50 mg/mL 81923-0367-00 | SKINS | 3 ml | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- FDA Orange Book · refreshed Oct 9, 2026
- CMS NADAC weekly file
Availability & generic status
🏛️
2008
On the market since
Jan 2008
📍
2026
Currently FDA-listed
18 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
- FDA Orange Book · refreshed Oct 9, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 936JST6JCN
Cetyl alcohol is a waxy, fatty substance derived from plant or animal sources. It acts as an emulsifier and thickener in medicines, helping blend oil and water components and giving products a smooth, creamy texture.
-
UNII PDC6A3C0OX
Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
-
UNII 230OU9XXE4
A waxy substance made from glycerin and stearic acid that acts as an emulsifier to blend oily and watery ingredients together. It also helps thicken and stabilize the medicine's texture.
-
UNII L605B5892V
A plant-derived thickener made from cellulose. It increases the medicine's thickness and helps it spread evenly, commonly used in gels, creams, and eye drops to improve texture and how the product coats or clings to surfaces.
-
UNII ND2M416302
Isopropyl alcohol is a clear liquid solvent derived from petroleum. In medicines, it dissolves active ingredients and other components, helps the product flow smoothly, and aids in sterilization during manufacturing.
-
UNII A2I8C7HI9T
Methylparaben is a preservative derived from benzoic acid that prevents growth of bacteria, fungi, and mold in medicines. It extends the product's shelf life and maintains safety during storage.
-
UNII 4T6H12BN9U
Petrolatum is a purified mineral oil-based jelly derived from petroleum. In medicines, it acts as an emollient, lubricant, and moisture barrier to soften skin, reduce friction, and help prevent water loss from formulations.
-
UNII Z8IX2SC1OH
Propylparaben is a chemical preservative used to prevent bacterial and fungal growth in medicines and personal care products. It helps extend shelf life and maintain product safety during storage.
-
UNII 368GB5141J
A detergent and foaming agent derived from coconut or palm oil. In medications, it helps break down and mix oil and water-based ingredients, aids in tablet disintegration, and improves how the drug dissolves and spreads in the mouth or digestive system.
-
UNII 4ELV7Z65AP
Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.
-
UNII 70FD1KFU70
Sulfur is a naturally occurring chemical element. It works as an anti-caking agent and preservative in medicines, helping the product stay dry and preventing spoilage.
-
UNII 9O3K93S3TK
Trolamine is an alkaline compound used as a pH buffer and emulsifier in medicines. It helps neutralize acids, stabilize formulations, and enable mixing of oil and water-based ingredients.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
13 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesCetyl alcohol. Glycerin, Glyceryl stearate, Hydroxyethyl cellulose, Isopropyl alcohol, Methylparaben, Petrolatum, Propylparaben, Purified water, Sodium lauryl sulfate, Stearic acid, Sulfur, and Triothanolamine..
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 8, 2026
- FDA openFDA NDC Directory · synced Oct 8, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerPharma Nobis, LLC
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code82645
First marketedJan 2008
Product typeHuman Otc Drug
Portfolio40 products on file
More NDCs from Pharma Nobis, LLC labeler code 82645
- Merthiolate Benzalkonium Chloride 1.3 mg/mL Liquid NDC 82645-912-92
- Isopropyl Rubbing Alcohol 70 Percent 700 mg/mL Liquid NDC 82645-913-16
- Isopropyl Alcohol 91 Percent 910 mg/mL Liquid NDC 82645-914-16
- Isopropyl Alcohol 70 Percent With Wintergreen Oil 700 mg/mL Liquid NDC 82645-915-16
- Humco Hydrogen Peroxide Hydrogen Peroxide 3% 30 mg/mL Liquid NDC 82645-916-16
- Gentian Violet 1% 10 mg/mL Liquid NDC 82645-917-91
- Humco Castor Oil 1 mg/mL Liquid NDC 82645-919-16
- Camphor Spirit Camphor 10% 100 mg/mL Liquid NDC 82645-920-92
- Calamine Phenolated Topical Suspension Calamine and Zinc Oxide and Phenol 160 mg/mL; 10 mg/mL Lotion NDC 82645-921-96
- Humco Calagesic Calamine and Pramoxine Hydrochloride 80 mg/mL; 10 mg/mL Lotion NDC 82645-922-96
- Calaclear Pramoxine Hydrochloride and Zinc Acetate 10 mg/mL; 1 mg/mL Lotion NDC 82645-923-96
- Benzoin Tincture Benzoin Resin 1000 mg/mL Liquid NDC 82645-924-92
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
📄 When Using This Product
📄 Keep Out of Reach of Children
📄 Other Information
📄 Package Label / Principal Display Panel
🎯 Indications and Usage ▾
Use Relieves itching and discomfort due to nonpoisonous insect bites such as chiggers (redbugs), mosquitoes, ticks, fleas, no-see-ums, biting flies, fire ants, bees and wasps; summer’s itch.
⏱️ Dosage and Administration ▾
Directions : As an anti-itch. Adults and children 2 yrs. o f age and over . Apply topically and rub well as needed. Children under 2 yrs. of age: Do not use As an insect (chigger) repellent: Apply around feet, ankles, waist and to skin under all areas of tight clothing and around all openings in outer clothing. Reapply after heavy perspiration.
⚠️ Warnings ▾
Warnings For external use only. Keep away from eyes or other mucous membranes. Not for prolonged use. For use on intact skin only. Do not use on children younger than 2 yrs. When using this product discontinue use if the condition persists or if a rash or irritation develops and consult a doctor. As with all pesticides/drugs, keep out of the reach of children. In case of accidental ingestion, contact physician or poison control center at once.
🧪 Active Ingredient ▾
Active Ingredient Benzocaine 5%
🧪 Inactive Ingredients ▾
Inactive Ingredient Cetyl alcohol. Glycerin, Glyceryl stearate, Hydroxyethyl cellulose, Isopropyl alcohol, Methylparaben, Petrolatum, Propylparaben, Purified water, Sodium lauryl sulfate, Stearic acid, Sulfur, and Triothanolamine..
🎯 Purpose ▾
Purpose Anesthetic
📄 When Using This Product ▾
When using this product discontinue use if the condition persists or if a rash or irritation develops and consult a doctor. As with all pesticides/drugs,
📄 Keep Out of Reach of Children ▾
keep out of the reach of children. In case of accidental ingestion, contact physician or poison control center at once.
📄 Other Information ▾
Other Information Disposal : Do not reuse bottle. Rinse thoroughly before discarding.
📄 Package Label / Principal Display Panel ▾
CVS PRINCIPAL DISPLAY PANEL Itch Relief & Repellent Relieves itching & Repels Chiggers ( Redbugs) 4 FL OZ (118 mL)
HEBChigg.jpg
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Benzocaine — the ingredient across all brands.
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but Pharma Nobis, LLC has reported a marketing end date of 2026-12-31, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Who lists this product with the FDA?
Pharma Nobis, LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.